---
figid: PMC6721829__cells-08-00840-g003
figlink: /pmc/articles/PMC6721829/figure/cells-08-00840-f003/
number: Figure 3
caption: 'Mechanistic overview of miRNA-mediated regulation of the stemness of cancer
  stem cells via targeting signaling pathways: miRNAs can act as both suppressive
  and enhancer of stem cells features such as self-renewal, sphere formation, cancer
  relapse, migration, invasion, and chemo- and radiotherapy resistance. Via targeting
  the Wnt/β-catenin signaling pathway, many miRNAs regulate the stem cell features
  by targeting β-catenin. Upregulation of miR-19, miR-501-5p, and miR-744 stimulates
  the activation of β-catenin. Hence, it is translocated to the nucleus and stimulates
  gene expression. Conversely, upregulation of miR-708-5p and miR-142-3p inhibits
  β-catenin activation and prevents its accumulation in the cytoplasm. Another signaling
  pathway targeted by miRNAs is AKT/PI3K/PTEN. MiR-21, miR-221/222, and miR-106b-5p
  upregulation inhibit the function of PTEN. Furthermore, upregulation of miR-21 and
  miR-23a stimulate the activation of the AKT/PI3K pathway, whereas upregulation of
  miR-128 inhibits its activation. Upregulation of miR-106b is found to act on TGF-β
  through targeting Smad. Downregulation of miR-200c stimulates the activation of
  Notch pathways and, hence, enhances CSC features. Another important signaling pathway
  associated with CSC development is the JAK/STAT pathway. Upregulation of miR-196b-5p
  and miR-500a-3p and downregulation of miR-218 stimulate the activation of STAT3
  molecule. Further, downregulation of miR-136 stimulates CSCs as a result of activating
  various proteins including NF-kB, survivin, cyclin D1, and Bcl2. In addition, upregulation
  of miR-155 activates NF-kB. Taken together, the stem cell features can be stimulated
  or suppressed by miRNA-regulated expression of signaling proteins.'
pmcid: PMC6721829
papertitle: Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human
  Malignancies.
reftext: Abdul Q. Khan, et al. Cells. 2019 Aug;8(8):840.
pmc_ranked_result_index: '7392'
pathway_score: 0.9680389
filename: cells-08-00840-g003.jpg
figtitle: Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies.
year: '2019'
organisms: Homo sapiens
ndex: 8c35b9cf-decb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6721829__cells-08-00840-g003.html
  '@type': Dataset
  description: 'Mechanistic overview of miRNA-mediated regulation of the stemness
    of cancer stem cells via targeting signaling pathways: miRNAs can act as both
    suppressive and enhancer of stem cells features such as self-renewal, sphere formation,
    cancer relapse, migration, invasion, and chemo- and radiotherapy resistance. Via
    targeting the Wnt/β-catenin signaling pathway, many miRNAs regulate the stem cell
    features by targeting β-catenin. Upregulation of miR-19, miR-501-5p, and miR-744
    stimulates the activation of β-catenin. Hence, it is translocated to the nucleus
    and stimulates gene expression. Conversely, upregulation of miR-708-5p and miR-142-3p
    inhibits β-catenin activation and prevents its accumulation in the cytoplasm.
    Another signaling pathway targeted by miRNAs is AKT/PI3K/PTEN. MiR-21, miR-221/222,
    and miR-106b-5p upregulation inhibit the function of PTEN. Furthermore, upregulation
    of miR-21 and miR-23a stimulate the activation of the AKT/PI3K pathway, whereas
    upregulation of miR-128 inhibits its activation. Upregulation of miR-106b is found
    to act on TGF-β through targeting Smad. Downregulation of miR-200c stimulates
    the activation of Notch pathways and, hence, enhances CSC features. Another important
    signaling pathway associated with CSC development is the JAK/STAT pathway. Upregulation
    of miR-196b-5p and miR-500a-3p and downregulation of miR-218 stimulate the activation
    of STAT3 molecule. Further, downregulation of miR-136 stimulates CSCs as a result
    of activating various proteins including NF-kB, survivin, cyclin D1, and Bcl2.
    In addition, upregulation of miR-155 activates NF-kB. Taken together, the stem
    cell features can be stimulated or suppressed by miRNA-regulated expression of
    signaling proteins.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NOTCH4
  - NOTCH1
  - NOTCH3
  - NFKB1
  - NOTCH2
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - JAK2
  - AKT2
  - PIK3R6
  - WNT10A
  - WNT5B
  - WNT3A
  - SMAD5
  - SMAD6
  - PTEN
  - PIK3R3
  - CTNNB1
  - CCND1
  - IL6
  - WNT2B
  - WNT9A
  - WNT9B
  - SMAD2
  - SMAD3
  - SMAD4
  - WNT5A
  - WNT6
  - SMAD7
  - SMAD9
  - STAT3
  - BCL2
  - WNT11
  - AKT3
  - AKT1
  - WNT4
  - WNT1
  - WNT2
  - WNT3
  - WNT8A
  - WNT8B
  - WNT7A
  - WNT7B
  - TGFB3
  - WNT16
  - WNT10B
  - TGFB2
  - SMAD1
  - TGFB1
  - Cancer
genes:
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH4
  entrez: '4855'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: NF-kB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: AKT/PI3K
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: B-Catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: BCL2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: AKT/PI3K
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT/PI3K
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
